Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis
John J. Lepore, … , Edward E. Morrisey, Michael S. Parmacek
John J. Lepore, … , Edward E. Morrisey, Michael S. Parmacek
Published April 3, 2006
Citation Information: J Clin Invest. 2006;116(4):929-939. https://doi.org/10.1172/JCI27363.
View: Text | PDF
Research Article Cardiology

GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis

  • Text
  • PDF
Abstract

GATA transcription factors play critical roles in restricting cell lineage differentiation during development. Here, we show that conditional inactivation of GATA-6 in VSMCs results in perinatal mortality from a spectrum of cardiovascular defects, including interrupted aortic arch and persistent truncus arteriosus. Inactivation of GATA-6 in neural crest recapitulates these abnormalities, demonstrating a cell-autonomous requirement for GATA-6 in neural crest–derived SMCs. Surprisingly, the observed defects do not result from impaired SMC differentiation but rather are associated with severely attenuated expression of semaphorin 3C, a signaling molecule critical for both neuronal and vascular patterning. Thus, the primary function of GATA-6 during cardiovascular development is to regulate morphogenetic patterning of the cardiac outflow tract and aortic arch. These findings provide new insights into the conserved functions of the GATA-4, -5, and -6 subfamily members and identify GATA-6 and GATA-6–regulated genes as candidates involved in the pathogenesis of congenital heart disease.

Authors

John J. Lepore, Patricia A. Mericko, Lan Cheng, Min Min Lu, Edward E. Morrisey, Michael S. Parmacek

×

Figure 1

Conditional targeting of murine GATA-6.

Options: View larger image (or click on image) Download as PowerPoint
Conditional targeting of murine GATA-6.
(A, top panel) GATA-6 locus cont...
(A, top panel) GATA-6 locus containing exons 3 and 4 (rectangles) and the targeting construct containing phosphoglycerate kinase–regulated (PGK-regulated) neo and HSV thymidine kinase (tk) genes. loxP sites (triangles) flank neo and exon 4 encoding the C-terminal zinc finger (Zn) DNA-binding domain. B, BamHI. (Middle panel) Conditionally targeted GATA-6 allele. (Bottom panel) Targeted allele following selective neo deletion. (B, left) Southern blotting (probe A) of targeted ES cells identifies wild-type (11.1 kb) and conditionally targeted (6.8 kb) alleles. (Right) Southern blotting (probe B) of ES cells following Cre transfection identifies wild-type (11.1 kb) and conditionally targeted alleles with neo (6.2 kb) and with selective neo deletion (4.3 kb). (C) Genotyping of wild-type (+/+), heterozygous (+/F), and homozygous (F/F) conditionally targeted mice. (Left) Southern blotting (probe B) identifies wild-type (11.1 kb) and conditionally targeted (4.3 kb) alleles. (Right) PCR using primers PCR-A and PCR-B identifies products corresponding to wild-type (150 bp) and targeted (110 bp) alleles. (D) Analysis of primary GATA-6F/F aortic SMCs infected with Ad-empty or Ad-Cre. RT-PCR identifies products corresponding to wild-type GATA-6 (373 bp) and GATA-6 following exon 4 deletion (285 bp). Western blotting (WB) identifies full-length (45 kDa) and truncated (41 kDa) GATA-6 proteins. (E) Activation of the GATA-dependent Dab2-LUC reporter. NIH3T3 cells were transiently transfected with 100 ng of the Dab2-LUC reporter and with 0.1–2.0 μg of either pcDNA3–GATA-6 or pcDNA3–GATA-6–Δexon4. The reporter was activated by expression of increasing amounts of wild-type GATA-6, but not by expression of the truncatedATA-6–Δexon4 protein.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts